🇺🇸 FDA
Patent

US 8835491

Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance

granted A61KA61K31/196A61K31/24

Quick answer

US patent 8835491 (Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents on Behalf of the University of Arizona
Grant date
Tue Sep 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/196, A61K31/24, A61K31/341, A61K31/4402